Hosted on MSN1mon
FDA approves SPRAVATO as first monotherapy for MDD
TITUSVILLE, N.J. - Johnson & Johnson (NYSE:JNJ) has received approval from the U.S. Food and Drug Administration (FDA) for SPRAVATO® (esketamine) nasal spray as a standalone treatment for adults ...
Hosted on MSN1mon
J&J's Depression Drug Spravato Gets FDA Nod for Monotherapy Use
Johnson & Johnson JNJ announced that the FDA has approved its supplemental new drug application (sNDA), seeking approval for Spravato (esketamine ... from $1.88 to $1.84 for 2025.
Psychology Today24d
Spravato Therapy Westmont
Stella Mental Health Westmont is a top depression and anxiety clinic near Chicago that offers comprehensive mental health treatments like Spravato (esketamine) therapy, ketamine infusion ...
Wane1mon
Viking Psychiatry: Spravato Approved as a Monotherapy
Living Local 15 host Jessica Williams is joined by Sean Goddard, a Psychiatric Nurse Practitioner and Owner of Viking Psychiatry, to speak about the recent approval for Spravato as a monotherapy ...
Psychology Today1y
Lucy Yusun Won
Spravato Treatment Center for Treatment Resistant Depression. T.O.V.A. neuropsychological assessment for ADHD provided. It is okay to reach out for help. In fact, acknowledging that you need help ...